Topical Corticosteroid Phobia in Childhood Atopic Dermatitis: A Study Using the TOPICOP Score
Dermatology Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/drp/7996688 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatology Research and Practice, online erschienen am 06.03.2026. Verfasst von Mateja Starbek Zorko und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Veneric Diseases, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia, uni-lj.si. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Topical corticosteroid phobia (CSP) is a significant barrier to the effective treatment of atopic dermatitis (AD). This is the first study to evaluate the CSP prevalence among parents of children with AD in Slovenia and to identify contributing factors.
Methods
We conducted a cross‐sectional study between March 2021 and December 2023. Parents of children with dermatologist‐confirmed AD, aged 3 months to 18 years, completed the validated TOPICOP questionnaire, supplemental questions and the (F)DLQI questionnaire. The SCORAD index was used to assess the severity of their children’s AD disease. Statistical analyses included the Shapiro–Wilk test, two‐tailed independent t ‐test, ANOVA, followed by Tukey post hoc testing and the Pearson correlation coefficient.
Results
Among 117 parents (81.2% mothers), the mean TOPICOP score was 48.2% (SD 15.1). Fear was the highest‐scoring TOPICOP domain (53.7%). CSP was significantly higher in parents of children with more severe AD based on SCORAD ( p = 0.033) and in families with higher (F)DLQI scores ( r = 0.311, p = 0.002). Notably, our results suggest that parents of children in single‐parent households had significantly higher CSP ( p = 0.035), a novel finding that warrants cautious interpretation due to the small subgroup size. Information obtained online about the potential dangers of topical corticosteroids (TCS) correlated with higher CSP ( p < 0.001).
Conclusion
CSP is prevalent among Slovenian parents of children with AD and is particularly pronounced in cases of more severe disease and single‐parent households, a novel and previously undescribed finding. Given that CSP is often influenced by nonmedical information sources, structured education and support by all healthcare providers is essential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Veneric Diseases, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia, uni-lj.si.
- Department of Dermatovenereology, University Medical Centre Ljubljana, Ljubljana, Slovenia, kclj.si.
- Emergency Department, Division of Internal Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia, kclj.si.
- Department of Dermatovenereology, Faculty of Medicine, University of Maribor, Maribor, Slovenia, um.si.
ORCID-Profile: Mateja Starbek Zorko, Vid Bukovec, Tanja Fantulin
Zitieren
APA
Starbek Zorko, M., Bukovec, V., & Fantulin, T. (2026). Topical Corticosteroid Phobia in Childhood Atopic Dermatitis: A Study Using the TOPICOP Score. Dermatology Research and Practice, 2026(1). https://doi.org/10.1155/drp/7996688
Vancouver
Starbek Zorko M, Bukovec V, Fantulin T. Topical Corticosteroid Phobia in Childhood Atopic Dermatitis: A Study Using the TOPICOP Score. Dermatology Research and Practice. 2026;2026(1). doi:10.1155/drp/7996688
BibTeX
@article{StarbekZorko2026,
author = {Starbek Zorko, Mateja and Bukovec, Vid and Fantulin, Tanja},
title = {Topical Corticosteroid Phobia in Childhood Atopic Dermatitis: A Study Using the TOPICOP Score},
journal = {Dermatology Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/drp/7996688}
}
EUVIMED